/HAE

Haemonetics Corp

HAE

$102.69USD↑+1.61%+1.63 today

MARKET CAP

4.7B

P/E (TTM)

28.3x

FWD P/E

—

DAY RANGE

$101 – $103

52W RANGE

$47

$110

AI Summary

Stalk

StalkMedium

HAE remains in a solid medium-term uptrend anchored by price above the 50- and 200-day SMAs, but short-term EMAs have flattened in a narrow consolidation. The lack of a clear breakout or breakdown suggests waiting for confirmation before new entries. We will stalk pullbacks into the converging 9- and 20-day EMA zone near recent support to align with the Stage 2 advance framework.

↑Q1 2027 revenue $339M (+6% YoY); adj. EPS $1.14 (+4%) beat consensus
↑Raised fiscal 2027 organic growth guidance to 4%–7%
↓Gross margin declined to 60.4% due to software license impacts and cost pressures

Full analysis →

Buying

10

institutions

Selling

5

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	5.91 M	443.19 M	+289.28 K	+39.9%	0.01%
AC Aqr Capital Management LLC Q2 2026	SELL	2.27 M	165.02 M	+-1.09 M	-11.1%	0.06%
AI Ariel Investments, LLC Q2 2026	BUYNEW	2.06 M	154.57 M	+2.06 M	+0.0%	1.54%
CA Citadel Advisors LLC Q2 2026	BUY	1.54 M	115.52 M	+1.26 M	+629.8%	0.01%
TR T. Rowe Price Investment Management, Inc. Q2 2026	BUY	1.10 M	82.60 M	+504.22 K	+145.4%	0.05%
MM Millennium Management LLC Q2 2026	BUY	670.41 K	50.28 M	+660.63 K	+9018.4%	0.02%
JH Janus Henderson Group Plc Q1 2026	BUY	372.33 K	20.98 M	+185.61 K	+40.2%	0.01%
JC Jpmorgan Chase & Co Q2 2026	SELL	227.89 K	17.28 M	+-101.02 K	-4.4%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	BUYNEW	134.98 K	10.12 M	+134.98 K	+0.0%	0.01%
RT Renaissance Technologies LLC Q2 2026	BUY	130.00 K	9.75 M	+86.80 K	+300.4%	0.01%
PA Point72 Asset Management, L.P. Q2 2026	BUY	109.24 K	8.19 M	+52.37 K	+155.6%	0.01%
BA Bridgewater Associates, LP Q2 2026	BUY	59.73 K	4.48 M	+11.36 K	+64.3%	0.02%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	526.00	39.45 K	+-365.00	-21.4%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-18.49 K	-100.0%	0.00%
HS Hussman Strategic Advisors, Inc. Q2 2026	SELL	0.00	0.00	+-10.50 K	-100.0%	0.00%